BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35634433)

  • 1. Design, synthesis and evaluation of amino-3,5-dicyanopyridines and thieno[2,3-b]pyridines as ligands of adenosine A
    Nkomba G; Terre'Blanche G; Janse van Rensburg HD; Legoabe LJ
    Med Chem Res; 2022; 31(8):1277-1297. PubMed ID: 35634433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chalcone-inspired rA
    Matthee C; Terre'Blanche G; Janse van Rensburg HD; Aucamp J; Legoabe LJ
    Chem Biol Drug Des; 2022 Mar; 99(3):416-437. PubMed ID: 34878728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives.
    Catarzi D; Varano F; Vigiani E; Calenda S; Melani F; Varani K; Vincenzi F; Pasquini S; Mennini N; Nerli G; Dal Ben D; Volpini R; Colotta V
    Pharmaceuticals (Basel); 2022 Apr; 15(4):. PubMed ID: 35455475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C3 amino-substituted chalcone derivative with selective adenosine
    Janse van Rensburg HD; Legoabe LJ; Terre'Blanche G
    Chem Zvesti; 2021; 75(4):1581-1605. PubMed ID: 33223599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors Ranging from Pan Ligands to Combined A
    Catarzi D; Varano F; Varani K; Vincenzi F; Pasquini S; Dal Ben D; Volpini R; Colotta V
    Pharmaceuticals (Basel); 2019 Oct; 12(4):. PubMed ID: 31652622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New fused pyrroles with rA1/A2A antagonistic activity as potential therapeutics for neurodegenerative disorders.
    van Vuuren NJ; van Rensburg HDJ; Terre'Blanche G; Legoabe LJ
    Mol Divers; 2022 Aug; 26(4):2211-2220. PubMed ID: 34741275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-amino-6-alkyloxy-2-alkylthiopyrimidine derivatives as novel non-nucleoside agonists for the adenosine A
    Cosimelli B; Greco G; Laneri S; Novellino E; Sacchi A; Trincavelli ML; Giacomelli C; Taliani S; Da Settimo F; Martini C
    Chem Biol Drug Des; 2016 Nov; 88(5):724-729. PubMed ID: 27282729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
    Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
    J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7-Amino-2-aryl/hetero-aryl-5-oxo-5,8-dihydro[1,2,4]triazolo[1,5-a]pyridine-6-carbonitriles: Synthesis and adenosine receptor binding studies.
    Shaik K; Deb PK; Mailavaram RP; Chandrasekaran B; Kachler S; Klotz KN; Jaber AMY
    Chem Biol Drug Des; 2019 Aug; 94(2):1568-1573. PubMed ID: 30985956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-Benzylaminoxanthine scaffold variations for selective ligands acting on adenosine A
    Załuski M; Schabikowski J; Jaśko P; Bryła A; Olejarz-Maciej A; Kaleta M; Głuch-Lutwin M; Brockmann A; Hinz S; Zygmunt M; Kuder K; Latacz G; Vielmuth C; Müller CE; Kieć-Kononowicz K
    Bioorg Chem; 2020 Aug; 101():104033. PubMed ID: 32629282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological investigation of new equatorial (β) stereoisomers of 3-aminotropane arylamides with atypical antipsychotic profile.
    Stefanowicz J; Słowiński T; Wróbel MZ; Herold F; Gomółka AE; Wesołowska A; Jastrzębska-Więsek M; Partyka A; Andres-Mach M; Czuczwar SJ; Łuszczki JJ; Zagaja M; Siwek A; Nowak G; Żołnierek M; Bączek T; Ulenberg S; Belka M; Turło J
    Bioorg Med Chem; 2016 Sep; 24(18):3994-4007. PubMed ID: 27377863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists.
    Baraldi PG; Cacciari B; Spalluto G; Bergonzoni M; Dionisotti S; Ongini E; Varani K; Borea PA
    J Med Chem; 1998 Jun; 41(12):2126-33. PubMed ID: 9622554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, adenosine receptor binding and molecular modelling studies of novel thieno[2,3-d]pyrimidine derivatives.
    Deb PK; Mailavaram R; Chandrasekaran B; Kaki VR; Kaur R; Kachler S; Klotz KN; Akkinepally RR
    Chem Biol Drug Des; 2018 Apr; 91(4):962-969. PubMed ID: 29194979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity.
    Betti M; Catarzi D; Varano F; Falsini M; Varani K; Vincenzi F; Pasquini S; di Cesare Mannelli L; Ghelardini C; Lucarini E; Dal Ben D; Spinaci A; Bartolucci G; Menicatti M; Colotta V
    J Med Chem; 2019 Aug; 62(15):6894-6912. PubMed ID: 31306001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing Substituents in the 1- and 3-Position: Tetrahydropyrazino-Annelated Water-Soluble Xanthine Derivatives as Multi-Target Drugs With Potent Adenosine Receptor Antagonistic Activity.
    Koch P; Brunschweiger A; Namasivayam V; Ullrich S; Maruca A; Lazzaretto B; Küppers P; Hinz S; Hockemeyer J; Wiese M; Heer J; Alcaro S; Kiec-Kononowicz K; Müller CE
    Front Chem; 2018; 6():206. PubMed ID: 29998095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New pyrazolo[3,4-b]pyridones as selective A(1) adenosine receptor antagonists: synthesis, biological evaluation and molecular modelling studies.
    Fossa P; Pestarino M; Menozzi G; Mosti L; Schenone S; Ranise A; Bondavalli F; Trincavelli ML; Lucacchini A; Martini C
    Org Biomol Chem; 2005 Jun; 3(12):2262-70. PubMed ID: 16010360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A
    Betti M; Catarzi D; Varano F; Falsini M; Varani K; Vincenzi F; Dal Ben D; Lambertucci C; Colotta V
    Eur J Med Chem; 2018 Apr; 150():127-139. PubMed ID: 29525433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A
    Squarcialupi L; Betti M; Catarzi D; Varano F; Falsini M; Ravani A; Pasquini S; Vincenzi F; Salmaso V; Sturlese M; Varani K; Moro S; Colotta V
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):248-263. PubMed ID: 28114825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A
    Barresi E; Giacomelli C; Daniele S; Tonazzini I; Robello M; Salerno S; Piano I; Cosimelli B; Greco G; Da Settimo F; Martini C; Trincavelli ML; Taliani S
    Bioorg Med Chem; 2018 Dec; 26(22):5885-5895. PubMed ID: 30415894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.